What is the Org number of NORSKE LEGER MOT ATOMVÅPEN?

NORSKE LEGER MOT ATOMVÅPEN is registered with Brønnøysundsregistrene under Org 971397225.

How many employees does NORSKE LEGER MOT ATOMVÅPEN have?

NORSKE LEGER MOT ATOMVÅPEN employs 6 people as of the latest annual report.

Anja Lingjerde Lillegraven is Chief Executive Officer of NORSKE LEGER MOT ATOMVÅPEN, in role since 2019.

Helene Kolstad Skovdahl chairs the board of NORSKE LEGER MOT ATOMVÅPEN, in role since 2025.

NORSKE LEGER MOT ATOMVÅPEN's registered address is Øvre Slottsgate 3, 0157 Oslo.

FLIActive

Org 971397225Øvre Slottsgate 3, 0157 OsloActivities of other membership organisations n.e.c. · NACE 9499Est. 19826 employeeswww.legermotatomvapen.no

Actively employed in the business

Name	Role	Member since
Current (1)
MF Maja Fjellvær Thompson Chief Executive Officer	Chief Executive Officer	2024
Former (2)
AL Anja Lingjerde Lillegraven Chief Executive Officer	Chief Executive Officer	2019 – 2023
EM Erik Martiniussen Chief Executive Officer	Chief Executive Officer	2023 – 2024

Non-executive oversight

Name	Role	Member since
Current (8)
HK Helene Kolstad Skovdahl	Deputy Chairman	2025
BH Bjørn Hilt	Board of Directors	2020
TB Thomas Bremnes	Board of Directors	2020
SA Signe Agnes Flottorp	Board of Directors	2025
SJ Simon Johan Mattias Andrup	Board of Directors	2024
KM Knut Mork Skagen	Chairman	2023
NA Nasradin Abdosh Bakare	Board of Directors	2025
MH Mathilde Hamre	Board of Directors	2023
Former (8)
GA Gard Aasmund Skulstad Johanson	Board of Directors	2022 – 2023
PT Petra Thee Lybæk	Board of Directors	2023 – 2025
CG Christian Grimsgaard	Board of Directors	2022 – 2023
MA Marianne Ask Torvik	Board of Directors	2022 – 2023
BC Beate Charlotte Lunde	Board of Directors	2020 – 2024
KE Knud Erik Alsbirk	Board of Directors	2023 – 2025
PL Petra Lybæk Heiberg	Board of Directors	2023 – 2024
HM Hanne Marie Skogen	Board of Directors	2020 – 2023

As of last annual report

No shareholder data available.

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.